-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic targeting of tumor angiogenesis: how far have we come?
Bruce C Baguley & Mark J McKeage
Clinical Trail Outcomes: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation